Health and Medicine

October 30, 2014

VU study reveals factor’s new role in cell division, migration

Vanderbilt University investigators have discovered a new molecular mechanism that regulates microtubule dynamics. The unexpected finding, reported in Developmental Cell, has implications for cancer drug discovery.

By Leigh MacMillan
October 29, 2014

Key to prostate cancer resistance

A combination of two types of therapy may be more effective in treating castration-resistant prostate cancer.

By VUMC News and Communications
October 28, 2014

Vanderbilt researchers isolate Ebola-fighting human antibodies for possible treatment

Vanderbilt University researchers have isolated Ebola-fighting human antibodies – the first of their kind – that could lead to a new treatment for the deadly virus.

By VUMC News and Communications
October 28, 2014

Peptide quells “genomic storm”

A cell-penetrating peptide developed at Vanderbilt blocks the signaling pathways that lead to lethal shock caused by bacterial infection.

By T.J. Utset
October 24, 2014

Immune cells’ role in hypertension

Vanderbilt researchers have discovered that certain immune cells contribute to the development of hypertension, suggesting novel targets for treating the disease.

By Leigh MacMillan
October 23, 2014

ResearchMatch database includes sub-registry for rare sarcoidosis

All ResearchMatch volunteers who self-report as having sarcoidosis will be prompted to answer additional questions to enhance the matching of volunteers with research teams who are studying this condition.

By Paul Govern
October 23, 2014

VICC investigators earn breast cancer grants

The grants, which total $830,000, are part of the non-profit organization’s commitment to young scientists, as well as established investigators who are searching for more effective breast cancer therapies.
By VUMC News and Communications
October 23, 2014

New view of transporter dynamics

New insights to the workings of a protein that moves neurotransmitters across the nerve cell membrane could aid the design of more effective antidepressants.
By Bill Snyder
October 23, 2014

‘Darting’ mice may hold clues to ADHD, autism and bipolar disorder

The transgenic mouse, into which was inserted a rare human genetic variation in the dopamine transporter, could lead to improvements in the diagnosis and treatment of these all-too-common brain disorders.
By Bill Snyder
October 20, 2014

New faculty: Dugan explores complexities of Alzheimer’s

Laura Dugan strives to bring breakthroughs in neuroscience research and the aging brain together.
By Nancy Humphrey
October 16, 2014

Staph ‘gangs’ share nutrients during infection: study

Antibiotic-resistant bacteria can share resources to cause chronic infections, Vanderbilt investigators have discovered. The findings shed light on a long-standing question in infectious diseases and may inform new treatment strategies.
By Leigh MacMillan
October 16, 2014

VUSN study seeks to improve lymphedema care

A new Vanderbilt University School of Nursing (VUSN) study may lead to earlier detection and better outcomes for the 20-30 percent of breast cancer patients with lymphedema, the painful and stigmatizing arm swelling that often results from treatment.
By VUMC News and Communications
October 16, 2014

Lymphocyte study reveals obesity clues

Vanderbilt University researchers are closer to understanding the link between obesity, chronic inflammation and type 2 diabetes.
By Bill Snyder
1 … 128 129 130 131 132 … 192